Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System (Butrans™) in Subjects With OA Pain

ClinicalTrials.gov ID: NCT00312572

Public ClinicalTrials.gov record NCT00312572. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 2:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind Study Evaluating the Dose Conversion From Vicodin® to Buprenorphine Transdermal System (BTDS) in Subjects With Osteoarthritis (OA) Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to evaluate the safety and efficacy of dose conversion from hydrocodone/ acetaminophen (Vicodin®) to the buprenorphine transdermal system (Butrans™) in subjects with osteoarthritis pain of the hip or knee. The double-blind treatment intervention duration is 2 weeks during which time supplemental analgesic medication will be allowed.

Study identification

NCT ID
NCT00312572
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Purdue Pharma LP
Industry
Enrollment
204 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2003 (Type not available)
Primary completion
Jul 2004 (Actual)
Completion
Jul 2004 (Actual)
Last update posted
Sep 3, 2012

2003 – 2004

United States locations

U.S. sites
36
U.S. states
20
U.S. cities
35
Facility City State ZIP Site status
Southern Drug Research Birmingham Alabama 35007 —
Redpoint Research Phoenix Arizona 85029 —
Advanced Clinical Therapeutics Tucson Arizona 85712 —
Tucson Orthopedic Institute Tucson Arizona 85712 —
Hot Springs Mercy Pain Clinic Hot Springs Arkansas 71913 —
Private Practice Pine Bluff Arkansas 71603 —
Advanced Clinical Research Institute Anaheim California 92801 —
Lovelace Scientific Resources Beverly Hills California 90211 —
Southbay Pharma Research Buena Park California 90620 —
Community Medical Providers Clovis California 93611 —
Kaiser Permanente Escondido California 92025 —
Univ. of Southern California Santa Monica California 90404 —
Arthritis Center of CT Waterbury Connecticut 06708 —
Lifespan Research Foundation, Inc. Miami Florida 33186 —
Miami Beach Anesthesiology Associates Miami Beach Florida 33140 —
Neuro Science and Spine Assoc. Naples Florida 34102 —
West Broward Rheumatology Association, Inc. Tamarac Florida 33321 —
Intermountain Orthopaedics Boise Idaho 83702 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Bluegrass Orthopaedics Lexington Kentucky 40509 —
Commonwealth Biomedical Research, LLC Madisonville Kentucky 42431 —
Dolby Providers, Inc. New Orleans Louisiana 70128 —
Clinical Pharmacology Study Group Worcester Massachusetts 01610 —
Westside Family Medical Center Kalamazoo Michigan 49009 —
PCM Medical Services Lansing Michigan 48917 —
HealthCare Research LLC St Louis Missouri 63141 —
Northeast Pain Research Center Barrington New Hampshire 03825 —
The Arthritis Clinic and Carolina Bone and Joint Charlotte North Carolina 28210 —
Dayton Primary and Urgent Care Dayton Ohio 45402 —
The Medford Medical Clinic Medford Oregon 97504 —
The Arthritis and Osteoporosis Center Orangeburg South Carolina 29118 —
CEDRA Clinical Research, Austin Texas 78759 —
Renaissance Clinical Research & Hypertension Clinic Dallas Texas 75235 —
Spine Care Southwest. Houston Texas 77074 —
KRK Medical Research Richardson Texas 75080 —
Monroe Medical Foundation Monroe Wisconsin 53566 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00312572, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 3, 2012 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00312572 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →